Although, the current sample size employed in this study is relatively limited, necessitating the acquisition of a more extensive sample cohort to substantiate the role of hypermethylated GRIA4 as a reliable biomarker for the early non-invasive detection of metastasis of clinically diagnosed cases of colorectal cancer. Here, GRIA4 is linked to colorectal cancer.